Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up

Y Fradet, J Bellmunt, DJ Vaughn, JL Lee, L Fong, NJ Vogelzang, MA Climent, DP Petrylak, TK Choueiri, A Necchi, W Gerritsen, H Gurney, DI Quinn, S Culine, CN Sternberg, K Nam, TL Frenkl, RF Perini, Ronald de Wit, DF Bajorin

Research output: Contribution to journalArticleAcademicpeer-review

229 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)970-976
Number of pages7
JournalAnnals of Oncology
Issue number6
Publication statusPublished - 2019

Cite this